Klevra Soln. 500mg/5mL CP 1X60mL

Generic Name: Levetiracetam
Therapeutic Segment: Anticonvulsants

Indication:

• Partial Onset Seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed Epilepsy, monoclonal seizures.

Available as: Tablets
Strength: 250 mg, 500 mg

Available as: Solution
Strength: 500 mg/5 ml

Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. Levetiracetam is indicated in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. Levetiracetam is indicated in the treatment of primary generalised tonic-clonic seizures

PRESENTATION

Klevra® 250mg tablet: 3x10 film coated tablets Klevra® 500mg tablet: 3x10 film coated tablets STORAGE

CONDITIONS

Store below 30ºC. Protect from heat, light and moisture . Keep all medicines out of the reach of children.